Comparative Pharmacology
Head-to-head clinical analysis: OXYCODONE AND ASPIRIN versus QDOLO.
Peer-Reviewed Evidence
Head-to-head clinical analysis: OXYCODONE AND ASPIRIN versus QDOLO.
OXYCODONE AND ASPIRIN vs QDOLO
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Oxycodone: mu-opioid receptor agonist; Aspirin: irreversible cyclooxygenase (COX-1 and COX-2) inhibitor, reducing prostaglandin synthesis.
Tramadol is a centrally acting synthetic opioid analgesic. It binds to μ-opioid receptors and inhibits norepinephrine and serotonin reuptake.
1 tablet (oxycodone 4.5 mg/aspirin 325 mg) orally every 6 hours as needed for pain; maximum 4 tablets in 24 hours.
Oral: 50-100 mg every 4-6 hours as needed for pain; maximum 400 mg per day. Immediate-release tablets only. Extended-release formulations require different dosing and are not interchangeable.
None Documented
None Documented
Oxycodone: 3-5 hours (immediate-release); 4.5-8 hours (extended-release). Aspirin (salicylate): 2-3 hours (low dose), 15-30 hours (high dose due to saturation of metabolic pathways).
Terminal elimination half-life approximately 2-4 hours in adults; prolonged to 4-6 hours in elderly and up to 12-16 hours in severe renal impairment (CrCl <30 mL/min)
Oxycodone: renal (primarily as noroxycodone) 87%, fecal <10%. Aspirin (as salicylate): renal 50-80% (dose-dependent; alkaline urine increases excretion), with biliary elimination of metabolites.
Renal 90% (60% unchanged, 30% as glucuronide conjugate), fecal 10%
Category D/X
Category C
Opioid Agonist
Opioid Agonist